Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer
NCT01688414 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2014-07-29
Summary
This pilot clinical trial studies imaging during surgery in diagnosing patients with prostate, bladder, or kidney cancer. New diagnostic imaging procedures, may find prostate, bladder, or kidney cancer
Conditions
- Bladder Cancer
- Kidney Tumor
- Prostate Cancer
Interventions
- PROCEDURE
-
photoacoustic imaging
Undergo PAI
- PROCEDURE
-
fluorescence imaging
Undergo fluorescence imaging
- PROCEDURE
-
robot-assisted laparoscopic surgery
Undergo robot-assisted laparoscopic surgery
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH - lead OTHER
Principal Investigators
-
Mark Gonzalgo · Stanford University
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-09-30
- Primary Completion
- 2015-09-30
More Related Trials
-
CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution
NCT00643994 ·Status: COMPLETED ·Phase: NA
-
Fusion Guided Focal Laser Ablation of Prostate Cancer
NCT02759744 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate Cancer
NCT00581503 ·Status: WITHDRAWN
-
68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery
NCT02678351 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Guided Biopsy for Mapping Prostate Cancer
NCT01007214 ·Status: TERMINATED ·Phase: NA
-
68Ga-PSMA-11 PET/CT in Imaging Patients With Intermediate or High Risk Prostate Cancer Before Surgery
NCT03368547 ·Status: COMPLETED ·Phase: NA
-
Gallium-68 Citrate PET Used in Prostate Cancer
NCT02391025 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the Prostate
NCT01028885 ·Status: COMPLETED ·Phase: PHASE1
-
Imaging of Residual Tumor During Prostatectomy
NCT01173146 ·Status: WITHDRAWN
-
CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry
NCT00643617 ·Status: COMPLETED ·Phase: NA
-
Positron Emission Tomography and Magnetic Resonance Imaging for Prostate Cancer
NCT00924313 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Focal Prostate Radio-Frequency Ablation
NCT02328807 ·Status: COMPLETED ·Phase: NA
-
Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer
NCT00619515 ·Status: TERMINATED ·Phase: NA
-
Improving Cancer Foci Detection in Prostate Cancer Using Multiparametric MRI/MRS
NCT01766869 ·Status: WITHDRAWN
-
Ultra-hypofractionated Radiation in Prostate Cancer
NCT03486821 ·Status: COMPLETED ·Phase: NA
-
Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer
NCT03444844 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Verification of Shear Wave Elastography for DEtection of Prostate Cancer
NCT04836949 ·Status: UNKNOWN ·Phase: NA
-
Hypofractionated Radiotherapy for Localized Prostate Cancer (With CyberKnife or With IMRT)
NCT00855647 ·Status: COMPLETED ·Phase: PHASE2
-
Hypofractionated Whole Pelvic Radiotherapy of the Prostate
NCT02546427 ·Status: WITHDRAWN ·Phase: NA
-
Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate Cancer
NCT02048150 ·Status: COMPLETED ·Phase: PHASE1
-
High-Intensity Focused Ultrasound in Treating Participants With Intermediate and High-risk Prostate Cancer
NCT03514927 ·Status: WITHDRAWN ·Phase: NA
-
Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer.
NCT05148156 ·Status: SUSPENDED ·Phase: NA
-
Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients
NCT02919111 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging
NCT04981223 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
High-Intensity Focused Ultrasound Ablation in Treating Patients With Progressive Prostate Cancer
NCT00987675 ·Status: UNKNOWN ·Phase: PHASE2